No, tirzepatide is not FDA-approved for hypertension treatment and should not replace standard antihypertensive therapy
[30] Entry into host cells occur through complex interactions between virions, especially through their glycoproteins, and cell-surface molecules CD81, LDL receptor, SR-BI, DC-SIGN, Claudin-1, and Occludin
Maintenance Dosage: Depending on the number of maintenance injections/oral supplements, the cost will vary
Their approach was straightforward and practical: Do tirzepatide and semaglutide protect against heart attack, stroke, and death when used in routine care and not in a clinical trial
J Diabetes Complications 37(8):108529 Mahapatra MK, Karuppasamy M, Sahoo BM (2022) Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes